Compounds > mefloquine hydrochloride

mefloquine hydrochloride and rifampin

mefloquine hydrochloride has been researched along with rifampin in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (44.44)	29.6817
2010's	5 (55.56)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gerena, L; Milhous, WK; Opsenica, D; Pocsfalvi, G; Solaja, BA; Terzić, N; Tinant, B	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Franzblau, SG; Kozikowski, AP; Lilienkampf, A; Mao, J; Wan, B; Wang, Y	1
Franzblau, SG; Huang, Q; Kozikowski, AP; Mao, J; Pieroni, M; van Breemen, RB; Wan, B; Wang, Y; Yuan, H	1
Franzblau, SG; Kozikowski, AP; Lilienkampf, A; Pieroni, M; Wan, B; Wang, Y	1
Franzblau, SG; He, R; Mao, J; Pak, D; Wan, B; Wang, Y; Yuan, H	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Adhikari, AV; Chowdhury, IH; Eswaran, S; Pal, NK; Thomas, KD	1
Barry, CE; Dartois, V	1

Reviews

1 review(s) available for mefloquine hydrochloride and rifampin

Article	Year
A medicinal chemists' guide to the unique difficulties of lead optimization for tuberculosis. Bioorganic & medicinal chemistry letters, 2013, Sep-01, Volume: 23, Issue:17 Topics: Animals; Antitubercular Agents; Drug Discovery; Humans; Lung; Mycobacterium tuberculosis; Tuberculosis	2013

Other Studies

8 other study(ies) available for mefloquine hydrochloride and rifampin

Article	Year
Mixed steroidal 1,2,4,5-tetraoxanes: antimalarial and antimycobacterial activity. Journal of medicinal chemistry, 2002, Aug-01, Volume: 45, Issue:16 Topics: Animals; Anti-Bacterial Agents; Antimalarials; Chlorocebus aethiops; Crystallography, X-Ray; Inhibitory Concentration 50; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plasmodium falciparum; Spectrometry, Mass, Electrospray Ionization; Spiro Compounds; Steroids; Structure-Activity Relationship; Vero Cells	2002
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis. Journal of medicinal chemistry, 2009, Apr-09, Volume: 52, Issue:7 Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Isoxazoles; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quinolines; Structure-Activity Relationship; Vero Cells	2009
From serendipity to rational antituberculosis drug discovery of mefloquine-isoxazole carboxylic acid esters. Journal of medicinal chemistry, 2009, Nov-26, Volume: 52, Issue:22 Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Drug Discovery; Esters; Female; Humans; Isoxazoles; Mefloquine; Mice; Microbial Sensitivity Tests; Microsomes, Liver; Mycobacterium tuberculosis; Vero Cells	2009
Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of Mycobacterium tuberculosis. a potent and selective series for further drug development. Journal of medicinal chemistry, 2010, Jan-28, Volume: 53, Issue:2 Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Drug Design; Drug Resistance, Bacterial; Esters; Isoxazoles; Mycobacterium tuberculosis; Structure-Activity Relationship; Vero Cells	2010
Synthesis and antituberculosis activity of novel mefloquine-isoxazole carboxylic esters as prodrugs. Bioorganic & medicinal chemistry letters, 2010, Feb-01, Volume: 20, Issue:3 Topics: Antitubercular Agents; Carboxylic Acids; Esters; Humans; Isoxazoles; Mefloquine; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prodrugs	2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
New quinoline derivatives: synthesis and investigation of antibacterial and antituberculosis properties. European journal of medicinal chemistry, 2010, Volume: 45, Issue:8 Topics: Antitubercular Agents; Bacteria; Crystallography, X-Ray; Microbial Sensitivity Tests; Quinolines	2010